Safety following covid-19 booster vaccine with bnt162b2 compared to mrna-1273 in solid cancer patients previously vaccinated with chadox1 or coronavac

HIGHLIGHTS

• who: Passakorn Wanchaijiraboon et al. from the Phrapokklao Hospital, Mueang District, Chantaburi, Thailand Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand have published the research: Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac, in the Journal: Vaccines 2023, 356 of 31/Oct/2022
• what: As a result, the authors aimed to obtain safety data for the mRNA COVID-19 vaccine booster dose in solid cancer patients previously vaccinated with two doses of ChAdOx1 or heterogenous CoronaVac/ChAdOx1. The majority . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.